High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
In contrast to resource-rich countries, most HIV-infected patients in resource-limited countries receive treatment without virological monitoring. There are few long-term data, in this setting, on rates of viral suppression or switch to second-line antiretroviral therapy. The DART trial compared cli...
Auteurs principaux: | Kityo, C, Gibb, D, Gilks, C, Goodall, R, Mambule, I, Kaleebu, P, Pillay, D, Kasirye, R, Mugyenyi, P, Walker, A, Dunn, D |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Public Library of Science
2014
|
Documents similaires
-
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
par: Cissy Kityo, et autres
Publié: (2014-01-01) -
DART and laboratory monitoring of HIV treatment Reply
par: Walker, A, et autres
Publié: (2010) -
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).
par: Gilks, C, et autres
Publié: (2012) -
Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
par: Gomo, Z, et autres
Publié: (2014) -
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
par: Mugyenyi, P, et autres
Publié: (2010)